Q3 2020 Sales Performance

Headline results gsk Q3 2020 Reported % Pro forma Reported Pro forma YTD 2020 % % % £m AER CER CER £m AER CER CER Turnover 8,646 (8) (3) (5) 25,360 2 4 (2) Total operating profit 1,858 (13) (2) n/a 6,722 Total EPS 25.0p (20) (9) n/a 102.0p 355 33 51 35 37 n/a 55 n/a Adjusted operating profit 2,665 (4) 4 2 7,089 3 (3) Adjusted EPS 35.6p (8) 1 n/a 92.6p (7) (4) n/a Free cash flow (180) >(100) n/a n/a 2,300 (7) n/a n/a 87 22

View entire presentation